Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Bile Acid Binding Resins to Decrease Systemic Per- and Polyfluoroalkyl Substance (PFAS) Levels and Improve Serum Lipid Profiles in Veterans: PFAS Reduction in Veterans Via Colesevalem Study (PAVERS) Study

NCT07592858 is registered in ClinicalTrials.gov with University of Rhode Island as lead sponsor.

NCT NCT07592858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07592858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Bile Acid Binding Resins to Decrease Systemic Per- and Polyfluoroalkyl Substance (PFAS) Levels and Improve Serum Lipid Profiles in Veterans: PFAS Reduction in Veterans Via Colesevalem Study (PAVERS) Study
Lead sponsor
University of Rhode Island
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
September 29, 2029
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

burn pit exposure, environmental exposures, forever chemicals, hyperlipidemia (e.g., hypercholesterolemia), hyperlipidemias, hypercholesterolemia, mixed dyslipidemia, military exposure, occupational exposure to chemicals, pfas